- Global Pharma News & Resources

Mirador Global® Hires Two Key Execs to Further Expand Global Commercialization Consulting Services and Deepen Oncology Experience

These Hires further MIRADOR’s Mission to Help Biopharmaceutical Companies Develop Robust and Integrated Global Commercialization Strategies

DEVON, Pa.--(BUSINESS WIRE)--MIRADOR Global, a COEUS Holdings, LLC company, today announced that it has hired two key executives for its rapidly growing team. Kaylor Kowash, RPh, MBA was brought on as VP, Oncology Commercial Strategy and Christian Bennett will serve as VP, Global Market Access Strategy. The move comes just under one year since the MIRADOR Global joined the COEUS family of companies.

In their respective roles, both Kowash and Bennett will utilize their decades of experience to support MIRADOR clients in early phase forecasting and asset valuation support, global payer reimbursement, risk assessment and mitigation, and portfolio/product opportunity assessment and prioritization –all leading up to launch planning.

“We’re thrilled to add Kaylor Kowash and Christian Bennett to the MIRADOR Global team,” said Chuck Peipher, MIRADOR Global Founder & Managing Partner. “Each of them brings the pedigree necessary to facilitate a variety of MIRADOR Global services for our growing list of clients as they navigate the path to product approval.”

Kaylor will be directly responsible for leading MIRADOR’s Oncology Commercial Strategy team. He brings expertise in a wide range of tumor types including thoracic, breast, prostate and other cancers. In addition, he has extensive experience working in personalized medicine and biomarkers in the oncology marketplace.

In his new role at MIRADOR Global, Christian will be leading the expansion of global payer strategy capabilities with additional focus on market readiness. He brings years of payer strategy experience across therapeutic areas with strengths in oncology, rare disease, and neuroscience.

“The COEUS philosophy has always been that engaging clients early in the clinical development lifecycle will allow for optimal downstream success through greater identification and integration of payer, HCP, and patient insights,” stated Marc Hixson, Managing Director at COEUS Holdings, LLC. “With the addition of Kaylor and Christian, and the tremendous experience they’ll bring to our clients, MIRADOR Global is well positioned to address unmet needs in the design of the target product profile, evidence generation plans, and ultimately the successful commercialization of assets.”

Kaylor Kowash has 30+ years of bio-pharmaceutical industry experience. He has held leadership roles in Brand Marketing, Customer Marketing, Field Sales, Managed Markets, Key Account Management, and Medical Affairs including cross functional team leader responsibilities for both early-stage commercial development medicines and in-line flagship brands. With 20+ years in oncology, Kowash has worked on ten brands in oncology including targeted and hormonal therapies, immuno-oncology, and chemotherapy. In addition, he has had leadership roles on primary care brands treating cardiovascular disease, diabetes, and metabolic disorders. In addition, Kaylor has direct patient interaction experience via practicing pharmacy for 10+ years at a large teaching hospital in Philadelphia primarily focusing on cardiovascular critical care and in-patient oncology. His multi-faceted skill set delivers science and business talents to bridge the gaps that often exist between these two disciplines.

Christian Bennett has 20+ years of experience consulting to the biopharmaceutical industry, with significant experience in Pricing and Market Access (P&MA) strategy development. He has developed market access launch strategies across a wide range of products in oncology, immunology, dermatology, CNS, endocrinology, cardiovascular, as well as rare / orphan diseases. Bennett is recognized for developing highly actionable market access launch strategies, as well as depth in analytic-based access solutions including pricing and contracting strategies for both large and small manufacturers and biotech's. Prior to joining MIRADOR Global he was an SVP, Managing Director, of Precision Advisors (a Global market access strategy group). He also held senior leadership roles at ZS Associates and Syneos Health developing access strategy for biopharmaceutical clients.

About MIRADOR Global

Founded in 2016, Mirador Global is an international consulting practice that specializes in strategic global commercial development for specialty diseases, including rare diseases, oncology/​immuno-oncology, immunology, and CNS disorders. Mirador Global client engagements are developed bringing together Global Marketing, Analytics, Market Access, HEOR, Medical Affairs, R&D, and other functions delivered by a team of pharmaceutical industry experts. The company provides its clients with a bio-pharma line of sight unlike any other unique to MIRADOR Global. For more visit

About COEUS Holdings

Founded in 2020, COEUS Holdings, LLC and its subsidiaries form a boutique life sciences market access strategic and tactical consulting firm offering clients commercial support across the entire development spectrum. COEUS teams are singularly driven to optimize market access for pharmaceutical products. We are a multi-specialty, commercially aligned consultancy, offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients. Leveraging years of collective real-world market expertise, we offer unique perspectives into clinical and business opportunities to support your brands’ position in the marketplace. ​ For more information, please visit


Owen Murphy | 215.680.0155

Editor Details

  • Company:
    • Businesswire
Last Updated: 24-Oct-2021